4Egan KM,Wang M,Lucitt MB,et al.Cyclooxygenases,Thromboxane,and atherosclerosis:plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism.Circulation,2005,111:334 ～ 342.
5Mosheimer BA,Kaneider NC,Feistritzer C.CD40-ligand-dependent induction of COX-2 gene expression in endothelial cells by activated platelets:inhibitory effects of atorvastatin.Blood Coagulation & Fibrinolysis,2005,16:105 ～ 110.
6Chenevard R,Hurlimann D,Bechir M,et al.Selective COX-2 inhibition improves endothelial function in coronary artery disease.Circulation,2003,107:405 ～ 409.
7Grover SA,Coupal L,Zowall H.Treating osteoarthritis with cyclooxygenase-2-specific inhibitors:what are the benefits of avoiding blood pressure destabilization? Hypertension,2005,45:92 ～ 97.
8Hao CM,Breyer MD.Hypertension and cyclooxygenase-2 inhibitors:target:the renal medulla.Hypertension,2004,44:396 ～ 397.
9Hermann M,Shaw S,Kiss E,et al.Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension.Hypertension,2005,5:193 ～ 196.
10Solomon D,Schneeweiss S,Levin R,et al.Relationship between COX-2 specific inhibitors and hypertension.Hypertension,2004,44:140～145.
10Fabris S, Momo F, Ravagnan G, et al. Antioxidant Properties of Resveratrol and Piceid on Lipid Peroxidation in Micelles and Monolamellar Liposomes[J]. Biophysi Chem, 2008,135 (1-3) : 76-83.
